Immune thrombocytopenia relapse post covid-19 vaccine in young male patient

Area of Science:

• Hematology
• Immunology
• Vaccinology

Background:

• Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction.
• Coronavirus disease 2019 (COVID-19) can cause multisystemic complications.
• mRNA SARS-CoV-2 vaccines have been associated with rare cases of new-onset ITP.

Observation:

• A 28-year-old male with a history of ITP in partial remission received the second dose of the Pfizer-BioNTech COVID-19 vaccine.
• Four days post-vaccination, the patient experienced a severe relapse of ITP, with platelet counts dropping to 1 × 10^3 /µL.
• The patient required treatment with intravenous immunoglobulins and dexamethasone for the ITP relapse.

Findings:

• This case report documents a rare instance of ITP relapse following mRNA SARS-CoV-2 vaccination.
• The temporal association suggests a potential link between vaccination and ITP exacerbation in susceptible individuals.
• Few cases of ITP relapse post-vaccination have been previously reported.

Implications:

• Careful consideration and monitoring are warranted for ITP patients undergoing COVID-19 vaccination.
• Further research is needed to elucidate the pathophysiology of vaccine-induced ITP relapse.
• Management strategies for ITP patients considering vaccination should be discussed, balancing risks and benefits.